Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
3795 | 1906 | 26.3 | 56% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
8 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1276458 |
11 | 3 | ATRIAL FIBRILLATION//CARDIAC & CARDIOVASCULAR SYSTEM//CATHETER ABLATION | 130936 |
896 | 2 | AMIODARONE//ANTIARRHYTHMIC DRUGS//PROPAFENONE | 11339 |
3795 | 1 | PROPAFENONE//FLECAINIDE//MEXILETINE | 1906 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | PROPAFENONE | authKW | 614193 | 5% | 38% | 101 |
2 | FLECAINIDE | authKW | 369641 | 4% | 27% | 85 |
3 | MEXILETINE | authKW | 211479 | 3% | 23% | 57 |
4 | ORG 7797 | authKW | 112132 | 0% | 100% | 7 |
5 | ENCAINIDE | authKW | 96904 | 1% | 55% | 11 |
6 | 5 HYDROXYPROPAFENONE | authKW | 82381 | 0% | 86% | 6 |
7 | DIPRAFENONE | authKW | 64076 | 0% | 100% | 4 |
8 | AJMALINE | authKW | 35877 | 1% | 20% | 11 |
9 | 5 HYDROXY PROPAFENONE | authKW | 32038 | 0% | 100% | 2 |
10 | ANTIMYOTONIC AGENTS | authKW | 32038 | 0% | 100% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Cardiac & Cardiovascular System | 20963 | 41% | 0% | 787 |
2 | Pharmacology & Pharmacy | 7881 | 38% | 0% | 729 |
3 | Peripheral Vascular Diseases | 496 | 5% | 0% | 104 |
4 | Chemistry, Analytical | 489 | 8% | 0% | 158 |
5 | Medicine, General & Internal | 373 | 8% | 0% | 154 |
6 | Chemistry, Medicinal | 325 | 5% | 0% | 88 |
7 | Toxicology | 257 | 4% | 0% | 81 |
8 | Medical Laboratory Technology | 101 | 1% | 0% | 28 |
9 | Emergency Medicine | 101 | 1% | 0% | 22 |
10 | Biochemical Research Methods | 48 | 3% | 0% | 51 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CLIN NEW DRUGS THER EUT | 32038 | 0% | 100% | 2 |
2 | 48 BLVD SERURIER | 16019 | 0% | 100% | 1 |
3 | ABT ALLGMEINE PHARMAKOL | 16019 | 0% | 100% | 1 |
4 | AHMANSON PEDIAT PEDIAT CARDIOL | 16019 | 0% | 100% | 1 |
5 | BIO PROJECT 21 | 16019 | 0% | 100% | 1 |
6 | CARDIAC PAGING SERV | 16019 | 0% | 100% | 1 |
7 | CHILDRENS MEM HOSP PEDIAT CARDIOL | 16019 | 0% | 100% | 1 |
8 | CLIN ELE OPHYSIOL ECHOCARDIOGR H | 16019 | 0% | 100% | 1 |
9 | CLIN SUPPLIES OPERAT DISPENSARY GGPDC | 16019 | 0% | 100% | 1 |
10 | EARLY ADME GGPSE | 16019 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | AMERICAN JOURNAL OF CARDIOLOGY | 20301 | 10% | 1% | 184 |
2 | AMERICAN HEART JOURNAL | 12008 | 5% | 1% | 104 |
3 | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY | 9938 | 4% | 1% | 83 |
4 | CLINICAL PHARMACOLOGY & THERAPEUTICS | 8861 | 3% | 1% | 57 |
5 | ZEITSCHRIFT FUR KARDIOLOGIE | 6613 | 2% | 1% | 41 |
6 | EUROPEAN HEART JOURNAL | 6219 | 3% | 1% | 63 |
7 | EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 5822 | 3% | 1% | 51 |
8 | HERZ KREISLAUF | 4715 | 1% | 2% | 17 |
9 | JOURNAL OF CLINICAL PHARMACOLOGY | 3981 | 2% | 1% | 37 |
10 | ANNALES DE CARDIOLOGIE ET D ANGEIOLOGIE | 3537 | 1% | 1% | 18 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PROPAFENONE | 614193 | 5% | 38% | 101 | Search PROPAFENONE | Search PROPAFENONE |
2 | FLECAINIDE | 369641 | 4% | 27% | 85 | Search FLECAINIDE | Search FLECAINIDE |
3 | MEXILETINE | 211479 | 3% | 23% | 57 | Search MEXILETINE | Search MEXILETINE |
4 | ORG 7797 | 112132 | 0% | 100% | 7 | Search ORG+7797 | Search ORG+7797 |
5 | ENCAINIDE | 96904 | 1% | 55% | 11 | Search ENCAINIDE | Search ENCAINIDE |
6 | 5 HYDROXYPROPAFENONE | 82381 | 0% | 86% | 6 | Search 5+HYDROXYPROPAFENONE | Search 5+HYDROXYPROPAFENONE |
7 | DIPRAFENONE | 64076 | 0% | 100% | 4 | Search DIPRAFENONE | Search DIPRAFENONE |
8 | AJMALINE | 35877 | 1% | 20% | 11 | Search AJMALINE | Search AJMALINE |
9 | 5 HYDROXY PROPAFENONE | 32038 | 0% | 100% | 2 | Search 5+HYDROXY+PROPAFENONE | Search 5+HYDROXY+PROPAFENONE |
10 | ANTIMYOTONIC AGENTS | 32038 | 0% | 100% | 2 | Search ANTIMYOTONIC+AGENTS | Search ANTIMYOTONIC+AGENTS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | BRYSON, HM , PALMER, KJ , LANGTRY, HD , FITTON, A , (1993) PROPAFENONE - A REAPPRAISAL OF ITS PHARMACOLOGY, PHARMACOKINETICS AND THERAPEUTIC USE IN CARDIAC-ARRHYTHMIAS.DRUGS. VOL. 45. ISSUE 1. P. 85 -130 | 141 | 71% | 59 |
2 | LABBE, L , TURGEON, J , (1999) CLINICAL PHARMACOKINETICS OF MEXILETINE.CLINICAL PHARMACOKINETICS. VOL. 37. ISSUE 5. P. 361 -384 | 84 | 78% | 35 |
3 | MONK, JP , BROGDEN, RN , (1990) MEXILETINE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC USE IN THE TREATMENT OF ARRHYTHMIAS.DRUGS. VOL. 40. ISSUE 3. P. 374 -411 | 98 | 80% | 42 |
4 | FUNCKBRENTANO, C , KROEMER, HK , LEE, JT , RODEN, DM , (1990) DRUG-THERAPY - PROPAFENONE.NEW ENGLAND JOURNAL OF MEDICINE. VOL. 322. ISSUE 8. P. 518 -525 | 71 | 84% | 102 |
5 | HARRON, WG , BROGDEN, RN , (1987) PROPAFENONE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC USE IN THE TREATMENT OF ARRHYTHMIAS.DRUGS. VOL. 34. ISSUE 6. P. 617-647 | 75 | 91% | 51 |
6 | FABER, TS , CAMM, AJ , (1996) THE DIFFERENTIATION OF PROPAFENONE FROM OTHER CLASS IC AGENTS, FOCUSING ON THE EFFECT ON VENTRICULAR RESPONSE RATE ATTRIBUTABLE TO ITS BETA-BLOCKING ACTION.EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. VOL. 51. ISSUE 3-4. P. 199-208 | 63 | 73% | 3 |
7 | TAMARGO, J , CAPUCCI, A , MABO, P , (2012) SAFETY OF FLECAINIDE.DRUG SAFETY. VOL. 35. ISSUE 4. P. 273-289 | 48 | 52% | 9 |
8 | CATALANO, A , CAROCCI, A , SINICROPI, MS , (2015) MEXILETINE METABOLITES: A REVIEW.CURRENT MEDICINAL CHEMISTRY. VOL. 22. ISSUE 11. P. 1400 -1413 | 42 | 56% | 1 |
9 | HII, JTY , DUFF, HJ , BURGESS, ED , (1991) CLINICAL PHARMACOKINETICS OF PROPAFENONE.CLINICAL PHARMACOKINETICS. VOL. 21. ISSUE 1. P. 1 -10 | 50 | 88% | 31 |
10 | BROGDEN, RN , TODD, PA , (1987) ENCAINIDE - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC EFFICACY.DRUGS. VOL. 34. ISSUE 5. P. 519-538 | 60 | 90% | 6 |
Classes with closest relation at Level 1 |